中文

同仁堂 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-31

同仁堂 reported revenue of ¥8.38B for the period ended 2026-06-30, -14.2% year on year. Net income was ¥0.94B, a 11.2% net margin on a 42.4% gross margin. The largest revenue line is 其他主营业务 at 67% of the total. Free cash flow for the period was ¥0.72B.

ItemAmountY/Y
Revenue¥8.38B-14.2%
Gross profit¥3.55B
Operating income¥1.18B
Net income¥0.94B-29.9%
Gross margin42.4%Net margin 11.2%
Revenue Q/Q-20.3%

Revenue Segments

SegmentRevenueShare
其他主营业务¥5.58B66.5%
医药工业前五名系列¥2.76B32.9%
其他(补充)¥0.05B0.5%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥4.83B57.6%
R&D¥0.13B1.5%
SG&A¥2.18B26.1%
Tax & other¥0.25B2.9%

Balance sheet & cash flow

ItemAmount
Total assets¥29.95B
Total liabilities¥8.79B
Shareholders' equity¥21.16B
Equity / assets70.7%
Operating cash flow¥0.79B
Capital expenditure¥0.06B
Free cash flow¥0.72B
Cash conversion (OCF / net income)185%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

特变电工上汽集团北方稀土中国东航中国卫星中国船舶巨化股份中国巨石生益科技兖矿能源复星医药南山铝业

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies